The Ministry of Health focuses on six pillars to create a healthy society

We also aim to master vaccine production technology on the latest platforms, namely viral vectors and nucleic acids.

Jakarta (ANTARA) – The Ministry of Health is pursuing the transformation of the health system through six pillars to create a healthy, productive and equitable society, said the director general of pharmaceuticals and medical devices at the ministry, Roy Himawan.

“The Minister of Health has launched the transformation of the health system to create a more resilient health system in order to create a healthy, productive and just society,” he said during the opening seminar of the program “Training Superior of Trainers” on “Encouraging the Advancement of Health Biotechnology Education in Indonesia” here on Friday.

The six pillars of health transformation are Primary Services Transformation, Referral Services Transformation, Health Resilience System Transformation, Health Financing System Transformation, Health Human Resources Transformation and health technology transformation.

The transformation of the health system focuses on two areas: increasing the resilience of the pharmaceutical health sector and developing biotechnology, Himawan said.

Related news: Better biotech human resources are crucial for health services

In the pharmaceutical sector, over the next four years, Indonesia aims to master vaccine production for 14 national childhood immunization programs, he said.

“We also aim to master vaccine production technology on the latest platforms, namely viral vectors and nucleic acids. As President Joko Widodo inaugurated the mRNA platform vaccine production process, which will encourage our resilience in creating the latest biological products,” he said. said.

In the organic sector, the technology will specifically aim to produce organic products with local ingredients, he added. The products are insulin, antibody molecules and plasma products.

“It’s one of our goals for the next four years to be able to expand domestic production in Indonesia,” Himawan said.

Related News: Ministry Forms Team to Investigate Mysterious Acute Kidney Disorder

According to him, Indonesia has the potential to achieve maximum health development, supported by the upward trend in health expenditure.

However, health expenditures are used to secure health products in the form of medicines and medical devices, most of which are still imported.

“For our medicines, 90% of raw materials are still imported, and 88% of medical device transactions for two years have been imported products,” he said.

Therefore, collaboration between government, private sector and academia is needed to develop the most important aspect of biotechnology, namely human resources (HR), in order to improve the resilience of health to climate change. national scale through increased research.

“It can be concluded that we need to increase our research capacity, including research in the field of biotechnology,” he added.

Related News: Agreement on Equitable Access to Health Services Mechanism expected at 2nd HMM

Related News: Ministry Outlines COVID-19 Procedures for G20 Summit Delegates